Skip to main content
Theranostics logoLink to Theranostics
. 2021 Jan 1;11(5):2079. doi: 10.7150/thno.56734

TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis: Erratum

Han-Li Huang 1,2, Yi-Min Liu 1, Ting-Yi Sung 2, Tsui-Chin Huang 3, Ya-Wen Cheng 3, Jing-Ping Liou 1,4,, Shiow-Lin Pan 1,2,3,
PMCID: PMC7797671  PMID: 33500711

The authors wish to inform readers of a correction to the study. The informed consent and the IRB approval number in the Materials and methods section, should be revised as follows:

The human tissue biopsy samples used in this study were collected as part of a study approved by the human ethics committee of Taipei Medical University Joint Institutional Review Board (TMU-JIRB No. N201701061). The waiver of informed consent for the study was monitored by TMU-JIRB.

The authors regret the inconsistency and apologize for not identifying the issue earlier in the publication process.


Articles from Theranostics are provided here courtesy of Ivyspring International Publisher

RESOURCES